Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Harpoon Therapeutics (HARP) stocks in Canada

Learn how to easily invest in Harpoon Therapeutics stocks.

Harpoon Therapeutics is a biotechnology business based in the US. Harpoon Therapeutics stocks (HARP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $14 – an increase of 5.03% over the previous week. Harpoon Therapeutics employs 92 staff and has a trailing 12-month revenue of around $26.8 million.

How to buy shares in Harpoon Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HARP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Harpoon Therapeutics stock price (NASDAQ:HARP)

Use our graph to track the performance of HARP stocks over time.

Harpoon Therapeutics shares at a glance

Information last updated 2022-01-24.
Latest market close$5.43
52-week range$4.85 - $24.20
50-day moving average $6.66
200-day moving average $11.31
Wall St. target price$25.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.49

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Harpoon Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Harpoon Therapeutics price performance over time

Historical closes compared with the close of $5.43 from 2022-01-26

1 week (2022-01-17) N/A
1 month (2021-12-24) N/A
3 months (2021-10-28) -13.40%
6 months (2021-07-28) -49.11%
1 year (2021-01-28) -70.90%
2 years (2020-01-28) -62.83%
3 years (2019-01-24) N/A
5 years (2017-01-24) N/A

Harpoon Therapeutics financials

Revenue TTM $26.8 million
Gross profit TTM $-35,121,000
Return on assets TTM -19.82%
Return on equity TTM -154.71%
Profit margin 0%
Book value $2.35
Market capitalisation $179.5 million

TTM: trailing 12 months

Harpoon Therapeutics share dividends

We're not expecting Harpoon Therapeutics to pay a dividend over the next 12 months.

Harpoon Therapeutics share price volatility

Over the last 12 months, Harpoon Therapeutics's shares have ranged in value from as little as $4.85 up to $24.2. A popular way to gauge a stock's volatility is its "beta".

HARP.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harpoon Therapeutics's is 0.7813. This would suggest that Harpoon Therapeutics's shares are less volatile than average (for this exchange).

Harpoon Therapeutics overview

Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cell activating construct (TriTAC) product candidate is HPN424, which is in Phase I/IIa clinical trials for the treatment of metastatic castration-resistant prostate cancer. It is also developing HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian cancer and other mesothelin-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN328, a product candidate in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate our proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc.

Stocks similar to Harpoon Therapeutics

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site